Robert Jarvik animal in the lab for 10 days. Kolff assigned Jarvik to design a new heart that would overcome the problems of the Kwan-Gett heart, eventually culminating with the Jarvik-7 device. In 1982, the team carried out an artificial heart implant - the second ever, 13 years after Domingo Liotta and Denton Cooley's first in 1969. William DeVries first implanted the Jarvik-7 into retired dentist Barney Clark at the University of Utah on December 2, 1982. Clark required frequent visits to the hospital for the next 112 days, after which he died. During frequent press conferences to update the patient's condition,
Artificial cell cells have been proposed as a non-viral vector by which genetically modified non-autologous cells are encapsulated and implanted to deliver recombinant proteins "in vivo". This type of immuno-isolation has been proven efficient in mice through delivery of artificial cells containing mouse growth hormone which rescued a growth-retardation in mutant mice. A few strategies have advanced to human clinical trials for the treatment of pancreatic cancer, lateral sclerosis and pain control. The first clinical use of artificial cells was in hemoperfusion by the encapsulation of activated charcoal. Activated charcoal has the capability of adsorbing many large molecules and has for a